##  [Novartis highlights new CTL019 clinical data showing complete remissions in children and young adults with relapsed/refractory acute lymphoblastic leukemia](/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia-0 "Novartis highlights new CTL019 clinical data showing complete remissions in children and young adults with relapsed/refractory acute lymphoblastic leukemia") 

  Dec 06, 2014